Literature DB >> 3236368

Interstitial deletion 2q32.1----q34 in a child with half normal activity of ribulose 5-phosphate 3-epimerase (RPE).

K Miyazaki1, T Yamanaka, N Ogasawara.   

Abstract

High resolution banding analysis showed a de novo interstitial deletion, 46,XX, del(2) (q32.1q34), in a malformed and severely mentally retarded girl aged nine years. Biochemical studies showed that the proband had half normal activities of both erythrocyte isocitrate dehydrogenase (IDH1) and ribulose 5-phosphate 3-epimerase (RPE). It is suggested that the gene for RPE is located on the segment 2q32.1----q34.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3236368      PMCID: PMC1051616          DOI: 10.1136/jmg.25.12.850

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  4 in total

1.  Probable assignment of soluble isocitrate dehydrogenase (IDH1) to 2q33.3.

Authors:  K Narahara; S Kimura; K Kikkawa; Y Takahashi; Y Wakita; R Kasai; S Nagai; Y Nishibayashi; H Kimoto
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Spectrophotometric ass for D-ribose-5-phosphateketol-isomerase and for D-ribulose-5-phosphate 3-epimerase.

Authors:  T Wood
Journal:  Anal Biochem       Date:  1970-02       Impact factor: 3.365

3.  [Localization of the gene for ribulose-5-phosphate-3-epimerase on the 2q32 to 2qter segment by interspecies cellular hybridization].

Authors:  M S Gross; D Weil; C Finaz; C Foubert; C Cochet; I Parisi; J de Grouchy; J Frézal
Journal:  Ann Genet       Date:  1982

4.  Inhibitory effect of ethidium bromide on mitotic chromosome condensation and its application to high-resolution chromosome banding.

Authors:  T Ikeuchi
Journal:  Cytogenet Cell Genet       Date:  1984
  4 in total
  1 in total

1.  Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome.

Authors:  Jill A Rosenfeld; Blake C Ballif; Ann Lucas; Edward J Spence; Cynthia Powell; Arthur S Aylsworth; Beth A Torchia; Lisa G Shaffer
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.